nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Nucleoside Analog—Azathioprine—multiple sclerosis	0.449	1	CiPCiCtD
Emtricitabine—DCK—Cladribine—multiple sclerosis	0.242	1	CbGbCtD
Emtricitabine—Floxuridine—Cladribine—multiple sclerosis	0.158	0.625	CrCrCtD
Emtricitabine—Decitabine—Cladribine—multiple sclerosis	0.0953	0.376	CrCrCtD
Emtricitabine—DCK—Desoximetasone—Methylprednisolone—multiple sclerosis	0.000141	0.0885	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Betamethasone—multiple sclerosis	0.000139	0.0871	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Dexamethasone—multiple sclerosis	0.000139	0.0871	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Methylprednisolone—multiple sclerosis	0.000137	0.0859	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Triamcinolone—multiple sclerosis	0.000136	0.0851	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Betamethasone—multiple sclerosis	0.000135	0.0845	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Dexamethasone—multiple sclerosis	0.000135	0.0845	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Triamcinolone—multiple sclerosis	0.000132	0.0826	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Prednisone—multiple sclerosis	0.000129	0.0808	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Prednisolone—multiple sclerosis	0.000126	0.0788	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Prednisone—multiple sclerosis	0.000125	0.0784	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Prednisolone—multiple sclerosis	0.000122	0.0765	CbGdCrCtD
Emtricitabine—Neuropathy peripheral—Dexamethasone—multiple sclerosis	7.63e-05	0.00143	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Betamethasone—multiple sclerosis	7.63e-05	0.00143	CcSEcCtD
Emtricitabine—Myalgia—Mitoxantrone—multiple sclerosis	7.56e-05	0.00142	CcSEcCtD
Emtricitabine—Arthralgia—Mitoxantrone—multiple sclerosis	7.56e-05	0.00142	CcSEcCtD
Emtricitabine—Connective tissue disorder—Methylprednisolone—multiple sclerosis	7.55e-05	0.00142	CcSEcCtD
Emtricitabine—Diarrhoea—Cladribine—multiple sclerosis	7.54e-05	0.00142	CcSEcCtD
Emtricitabine—Anxiety—Mitoxantrone—multiple sclerosis	7.53e-05	0.00141	CcSEcCtD
Emtricitabine—Pancreatitis—Prednisone—multiple sclerosis	7.45e-05	0.0014	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Azathioprine—multiple sclerosis	7.33e-05	0.00138	CcSEcCtD
Emtricitabine—Dizziness—Cladribine—multiple sclerosis	7.29e-05	0.00137	CcSEcCtD
Emtricitabine—Infection—Mitoxantrone—multiple sclerosis	7.2e-05	0.00135	CcSEcCtD
Emtricitabine—Neutropenia—Prednisone—multiple sclerosis	7.11e-05	0.00133	CcSEcCtD
Emtricitabine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	7.1e-05	0.00133	CcSEcCtD
Emtricitabine—Abdominal pain—Azathioprine—multiple sclerosis	7.09e-05	0.00133	CcSEcCtD
Emtricitabine—Body temperature increased—Azathioprine—multiple sclerosis	7.09e-05	0.00133	CcSEcCtD
Emtricitabine—Skin disorder—Mitoxantrone—multiple sclerosis	7.04e-05	0.00132	CcSEcCtD
Emtricitabine—Vomiting—Cladribine—multiple sclerosis	7.01e-05	0.00132	CcSEcCtD
Emtricitabine—Rash—Cladribine—multiple sclerosis	6.95e-05	0.0013	CcSEcCtD
Emtricitabine—Dermatitis—Cladribine—multiple sclerosis	6.95e-05	0.0013	CcSEcCtD
Emtricitabine—Immune system disorder—Methylprednisolone—multiple sclerosis	6.94e-05	0.0013	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	6.92e-05	0.0013	CcSEcCtD
Emtricitabine—Headache—Cladribine—multiple sclerosis	6.91e-05	0.0013	CcSEcCtD
Emtricitabine—Weight decreased—Prednisone—multiple sclerosis	6.87e-05	0.00129	CcSEcCtD
Emtricitabine—Hyperglycaemia—Prednisone—multiple sclerosis	6.85e-05	0.00129	CcSEcCtD
Emtricitabine—Depression—Prednisone—multiple sclerosis	6.76e-05	0.00127	CcSEcCtD
Emtricitabine—Mental disorder—Methylprednisolone—multiple sclerosis	6.73e-05	0.00126	CcSEcCtD
Emtricitabine—Malnutrition—Methylprednisolone—multiple sclerosis	6.69e-05	0.00125	CcSEcCtD
Emtricitabine—Angioedema—Prednisolone—multiple sclerosis	6.66e-05	0.00125	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Prednisone—multiple sclerosis	6.64e-05	0.00125	CcSEcCtD
Emtricitabine—Breast disorder—Methotrexate—multiple sclerosis	6.64e-05	0.00125	CcSEcCtD
Emtricitabine—Hypersensitivity—Azathioprine—multiple sclerosis	6.61e-05	0.00124	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	6.6e-05	0.00124	CcSEcCtD
Emtricitabine—Nausea—Cladribine—multiple sclerosis	6.55e-05	0.00123	CcSEcCtD
Emtricitabine—Paraesthesia—Mitoxantrone—multiple sclerosis	6.51e-05	0.00122	CcSEcCtD
Emtricitabine—Back pain—Triamcinolone—multiple sclerosis	6.48e-05	0.00122	CcSEcCtD
Emtricitabine—Dyspnoea—Mitoxantrone—multiple sclerosis	6.46e-05	0.00121	CcSEcCtD
Emtricitabine—Dyspepsia—Mitoxantrone—multiple sclerosis	6.38e-05	0.0012	CcSEcCtD
Emtricitabine—Fatigue—Mitoxantrone—multiple sclerosis	6.25e-05	0.00117	CcSEcCtD
Emtricitabine—Pancreatitis—Methotrexate—multiple sclerosis	6.23e-05	0.00117	CcSEcCtD
Emtricitabine—Pain—Mitoxantrone—multiple sclerosis	6.2e-05	0.00116	CcSEcCtD
Emtricitabine—Diarrhoea—Azathioprine—multiple sclerosis	6.13e-05	0.00115	CcSEcCtD
Emtricitabine—Angioedema—Triamcinolone—multiple sclerosis	6.12e-05	0.00115	CcSEcCtD
Emtricitabine—Angioedema—Methylprednisolone—multiple sclerosis	6.11e-05	0.00115	CcSEcCtD
Emtricitabine—Connective tissue disorder—Prednisone—multiple sclerosis	5.98e-05	0.00112	CcSEcCtD
Emtricitabine—Neutropenia—Methotrexate—multiple sclerosis	5.94e-05	0.00111	CcSEcCtD
Emtricitabine—Dizziness—Azathioprine—multiple sclerosis	5.93e-05	0.00111	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	5.93e-05	0.00111	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	5.9e-05	0.00111	CcSEcCtD
Emtricitabine—Cough—Triamcinolone—multiple sclerosis	5.85e-05	0.0011	CcSEcCtD
Emtricitabine—Urticaria—Mitoxantrone—multiple sclerosis	5.76e-05	0.00108	CcSEcCtD
Emtricitabine—Abdominal pain—Mitoxantrone—multiple sclerosis	5.73e-05	0.00108	CcSEcCtD
Emtricitabine—Body temperature increased—Mitoxantrone—multiple sclerosis	5.73e-05	0.00108	CcSEcCtD
Emtricitabine—Myalgia—Triamcinolone—multiple sclerosis	5.7e-05	0.00107	CcSEcCtD
Emtricitabine—Vomiting—Azathioprine—multiple sclerosis	5.7e-05	0.00107	CcSEcCtD
Emtricitabine—Pneumonia—Methotrexate—multiple sclerosis	5.7e-05	0.00107	CcSEcCtD
Emtricitabine—Myalgia—Methylprednisolone—multiple sclerosis	5.69e-05	0.00107	CcSEcCtD
Emtricitabine—Arthralgia—Methylprednisolone—multiple sclerosis	5.69e-05	0.00107	CcSEcCtD
Emtricitabine—Anxiety—Methylprednisolone—multiple sclerosis	5.67e-05	0.00106	CcSEcCtD
Emtricitabine—Infestation NOS—Methotrexate—multiple sclerosis	5.66e-05	0.00106	CcSEcCtD
Emtricitabine—Infestation—Methotrexate—multiple sclerosis	5.66e-05	0.00106	CcSEcCtD
Emtricitabine—Rash—Azathioprine—multiple sclerosis	5.65e-05	0.00106	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	5.65e-05	0.00106	CcSEcCtD
Emtricitabine—Dermatitis—Azathioprine—multiple sclerosis	5.65e-05	0.00106	CcSEcCtD
Emtricitabine—Depression—Methotrexate—multiple sclerosis	5.65e-05	0.00106	CcSEcCtD
Emtricitabine—Headache—Azathioprine—multiple sclerosis	5.62e-05	0.00105	CcSEcCtD
Emtricitabine—Renal failure—Methotrexate—multiple sclerosis	5.57e-05	0.00104	CcSEcCtD
Emtricitabine—Angioedema—Betamethasone—multiple sclerosis	5.56e-05	0.00104	CcSEcCtD
Emtricitabine—Angioedema—Dexamethasone—multiple sclerosis	5.56e-05	0.00104	CcSEcCtD
Emtricitabine—Immune system disorder—Prednisone—multiple sclerosis	5.49e-05	0.00103	CcSEcCtD
Emtricitabine—Infection—Triamcinolone—multiple sclerosis	5.43e-05	0.00102	CcSEcCtD
Emtricitabine—Infection—Methylprednisolone—multiple sclerosis	5.42e-05	0.00102	CcSEcCtD
Emtricitabine—Haematuria—Methotrexate—multiple sclerosis	5.4e-05	0.00101	CcSEcCtD
Emtricitabine—Insomnia—Prednisolone—multiple sclerosis	5.38e-05	0.00101	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Methotrexate—multiple sclerosis	5.35e-05	0.00101	CcSEcCtD
Emtricitabine—Nervous system disorder—Methylprednisolone—multiple sclerosis	5.35e-05	0.001	CcSEcCtD
Emtricitabine—Hypersensitivity—Mitoxantrone—multiple sclerosis	5.34e-05	0.001	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisolone—multiple sclerosis	5.34e-05	0.001	CcSEcCtD
Emtricitabine—Mental disorder—Prednisone—multiple sclerosis	5.33e-05	0.001	CcSEcCtD
Emtricitabine—Nausea—Azathioprine—multiple sclerosis	5.33e-05	0.001	CcSEcCtD
Emtricitabine—Skin disorder—Methylprednisolone—multiple sclerosis	5.3e-05	0.000995	CcSEcCtD
Emtricitabine—Malnutrition—Prednisone—multiple sclerosis	5.29e-05	0.000994	CcSEcCtD
Emtricitabine—Asthenia—Mitoxantrone—multiple sclerosis	5.2e-05	0.000976	CcSEcCtD
Emtricitabine—Myalgia—Dexamethasone—multiple sclerosis	5.18e-05	0.000971	CcSEcCtD
Emtricitabine—Myalgia—Betamethasone—multiple sclerosis	5.18e-05	0.000971	CcSEcCtD
Emtricitabine—Anxiety—Betamethasone—multiple sclerosis	5.16e-05	0.000968	CcSEcCtD
Emtricitabine—Anxiety—Dexamethasone—multiple sclerosis	5.16e-05	0.000968	CcSEcCtD
Emtricitabine—Pain—Prednisolone—multiple sclerosis	5.08e-05	0.000954	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—multiple sclerosis	5.08e-05	0.000954	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—multiple sclerosis	5.04e-05	0.000947	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—multiple sclerosis	5.02e-05	0.000942	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—multiple sclerosis	4.98e-05	0.000935	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	4.98e-05	0.000935	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	4.97e-05	0.000933	CcSEcCtD
Emtricitabine—Diarrhoea—Mitoxantrone—multiple sclerosis	4.96e-05	0.000931	CcSEcCtD
Emtricitabine—Insomnia—Triamcinolone—multiple sclerosis	4.95e-05	0.000928	CcSEcCtD
Emtricitabine—Insomnia—Methylprednisolone—multiple sclerosis	4.93e-05	0.000926	CcSEcCtD
Emtricitabine—Infection—Betamethasone—multiple sclerosis	4.93e-05	0.000925	CcSEcCtD
Emtricitabine—Infection—Dexamethasone—multiple sclerosis	4.93e-05	0.000925	CcSEcCtD
Emtricitabine—Paraesthesia—Triamcinolone—multiple sclerosis	4.91e-05	0.000922	CcSEcCtD
Emtricitabine—Paraesthesia—Methylprednisolone—multiple sclerosis	4.9e-05	0.00092	CcSEcCtD
Emtricitabine—Anaemia—Prednisone—multiple sclerosis	4.89e-05	0.000918	CcSEcCtD
Emtricitabine—Dyspnoea—Triamcinolone—multiple sclerosis	4.88e-05	0.000915	CcSEcCtD
Emtricitabine—Nervous system disorder—Dexamethasone—multiple sclerosis	4.87e-05	0.000913	CcSEcCtD
Emtricitabine—Nervous system disorder—Betamethasone—multiple sclerosis	4.87e-05	0.000913	CcSEcCtD
Emtricitabine—Thrombocytopenia—Betamethasone—multiple sclerosis	4.86e-05	0.000912	CcSEcCtD
Emtricitabine—Thrombocytopenia—Dexamethasone—multiple sclerosis	4.86e-05	0.000912	CcSEcCtD
Emtricitabine—Angioedema—Prednisone—multiple sclerosis	4.84e-05	0.000908	CcSEcCtD
Emtricitabine—Dyspepsia—Triamcinolone—multiple sclerosis	4.81e-05	0.000903	CcSEcCtD
Emtricitabine—Dyspepsia—Methylprednisolone—multiple sclerosis	4.8e-05	0.000901	CcSEcCtD
Emtricitabine—Urticaria—Prednisolone—multiple sclerosis	4.72e-05	0.000887	CcSEcCtD
Emtricitabine—Fatigue—Triamcinolone—multiple sclerosis	4.71e-05	0.000885	CcSEcCtD
Emtricitabine—Fatigue—Methylprednisolone—multiple sclerosis	4.7e-05	0.000883	CcSEcCtD
Emtricitabine—Pain—Triamcinolone—multiple sclerosis	4.68e-05	0.000878	CcSEcCtD
Emtricitabine—Vomiting—Mitoxantrone—multiple sclerosis	4.61e-05	0.000865	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—multiple sclerosis	4.59e-05	0.000862	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—multiple sclerosis	4.58e-05	0.00086	CcSEcCtD
Emtricitabine—Rash—Mitoxantrone—multiple sclerosis	4.57e-05	0.000858	CcSEcCtD
Emtricitabine—Dermatitis—Mitoxantrone—multiple sclerosis	4.57e-05	0.000857	CcSEcCtD
Emtricitabine—Headache—Mitoxantrone—multiple sclerosis	4.54e-05	0.000852	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	4.52e-05	0.000848	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	4.52e-05	0.000848	CcSEcCtD
Emtricitabine—Arthralgia—Prednisone—multiple sclerosis	4.51e-05	0.000846	CcSEcCtD
Emtricitabine—Myalgia—Prednisone—multiple sclerosis	4.51e-05	0.000846	CcSEcCtD
Emtricitabine—Anxiety—Prednisone—multiple sclerosis	4.49e-05	0.000843	CcSEcCtD
Emtricitabine—Insomnia—Betamethasone—multiple sclerosis	4.49e-05	0.000842	CcSEcCtD
Emtricitabine—Insomnia—Dexamethasone—multiple sclerosis	4.49e-05	0.000842	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	4.48e-05	0.00084	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	4.46e-05	0.000837	CcSEcCtD
Emtricitabine—Paraesthesia—Dexamethasone—multiple sclerosis	4.46e-05	0.000836	CcSEcCtD
Emtricitabine—Paraesthesia—Betamethasone—multiple sclerosis	4.46e-05	0.000836	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—multiple sclerosis	4.45e-05	0.000836	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—multiple sclerosis	4.42e-05	0.00083	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisolone—multiple sclerosis	4.38e-05	0.000822	CcSEcCtD
Emtricitabine—Dyspepsia—Dexamethasone—multiple sclerosis	4.37e-05	0.00082	CcSEcCtD
Emtricitabine—Dyspepsia—Betamethasone—multiple sclerosis	4.37e-05	0.00082	CcSEcCtD
Emtricitabine—Urticaria—Triamcinolone—multiple sclerosis	4.34e-05	0.000815	CcSEcCtD
Emtricitabine—Urticaria—Methylprednisolone—multiple sclerosis	4.33e-05	0.000814	CcSEcCtD
Emtricitabine—Body temperature increased—Triamcinolone—multiple sclerosis	4.32e-05	0.000811	CcSEcCtD
Emtricitabine—Abdominal pain—Methylprednisolone—multiple sclerosis	4.31e-05	0.00081	CcSEcCtD
Emtricitabine—Nausea—Mitoxantrone—multiple sclerosis	4.31e-05	0.000808	CcSEcCtD
Emtricitabine—Infection—Prednisone—multiple sclerosis	4.29e-05	0.000806	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	4.28e-05	0.000804	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	4.28e-05	0.000804	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—multiple sclerosis	4.28e-05	0.000803	CcSEcCtD
Emtricitabine—Fatigue—Dexamethasone—multiple sclerosis	4.28e-05	0.000803	CcSEcCtD
Emtricitabine—Fatigue—Betamethasone—multiple sclerosis	4.28e-05	0.000803	CcSEcCtD
Emtricitabine—Pain—Dexamethasone—multiple sclerosis	4.24e-05	0.000796	CcSEcCtD
Emtricitabine—Pain—Betamethasone—multiple sclerosis	4.24e-05	0.000796	CcSEcCtD
Emtricitabine—Nervous system disorder—Prednisone—multiple sclerosis	4.24e-05	0.000795	CcSEcCtD
Emtricitabine—Skin disorder—Prednisone—multiple sclerosis	4.2e-05	0.000788	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—multiple sclerosis	4.09e-05	0.000768	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Betamethasone—multiple sclerosis	4.06e-05	0.000762	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	4.06e-05	0.000762	CcSEcCtD
Emtricitabine—Hypersensitivity—Triamcinolone—multiple sclerosis	4.03e-05	0.000756	CcSEcCtD
Emtricitabine—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.02e-05	0.000754	CcSEcCtD
Emtricitabine—Urticaria—Dexamethasone—multiple sclerosis	3.94e-05	0.00074	CcSEcCtD
Emtricitabine—Urticaria—Betamethasone—multiple sclerosis	3.94e-05	0.00074	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	3.94e-05	0.000739	CcSEcCtD
Emtricitabine—Dizziness—Prednisolone—multiple sclerosis	3.93e-05	0.000738	CcSEcCtD
Emtricitabine—Asthenia—Triamcinolone—multiple sclerosis	3.92e-05	0.000736	CcSEcCtD
Emtricitabine—Abdominal pain—Betamethasone—multiple sclerosis	3.92e-05	0.000736	CcSEcCtD
Emtricitabine—Body temperature increased—Dexamethasone—multiple sclerosis	3.92e-05	0.000736	CcSEcCtD
Emtricitabine—Abdominal pain—Dexamethasone—multiple sclerosis	3.92e-05	0.000736	CcSEcCtD
Emtricitabine—Body temperature increased—Betamethasone—multiple sclerosis	3.92e-05	0.000736	CcSEcCtD
Emtricitabine—Asthenia—Methylprednisolone—multiple sclerosis	3.91e-05	0.000735	CcSEcCtD
Emtricitabine—Insomnia—Prednisone—multiple sclerosis	3.91e-05	0.000734	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisone—multiple sclerosis	3.88e-05	0.000728	CcSEcCtD
Emtricitabine—Pruritus—Triamcinolone—multiple sclerosis	3.87e-05	0.000726	CcSEcCtD
Emtricitabine—Cough—Methotrexate—multiple sclerosis	3.86e-05	0.000725	CcSEcCtD
Emtricitabine—Pruritus—Methylprednisolone—multiple sclerosis	3.86e-05	0.000725	CcSEcCtD
Emtricitabine—Dyspepsia—Prednisone—multiple sclerosis	3.8e-05	0.000714	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—multiple sclerosis	3.77e-05	0.000707	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—multiple sclerosis	3.77e-05	0.000707	CcSEcCtD
Emtricitabine—Rash—Prednisolone—multiple sclerosis	3.75e-05	0.000704	CcSEcCtD
Emtricitabine—Dermatitis—Prednisolone—multiple sclerosis	3.75e-05	0.000703	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	3.74e-05	0.000702	CcSEcCtD
Emtricitabine—Diarrhoea—Methylprednisolone—multiple sclerosis	3.73e-05	0.000701	CcSEcCtD
Emtricitabine—Fatigue—Prednisone—multiple sclerosis	3.73e-05	0.000699	CcSEcCtD
Emtricitabine—Headache—Prednisolone—multiple sclerosis	3.73e-05	0.000699	CcSEcCtD
Emtricitabine—Dizziness—Triamcinolone—multiple sclerosis	3.62e-05	0.000679	CcSEcCtD
Emtricitabine—Dizziness—Methylprednisolone—multiple sclerosis	3.61e-05	0.000677	CcSEcCtD
Emtricitabine—Infection—Methotrexate—multiple sclerosis	3.59e-05	0.000673	CcSEcCtD
Emtricitabine—Asthenia—Betamethasone—multiple sclerosis	3.56e-05	0.000668	CcSEcCtD
Emtricitabine—Asthenia—Dexamethasone—multiple sclerosis	3.56e-05	0.000668	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—multiple sclerosis	3.54e-05	0.000665	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—multiple sclerosis	3.54e-05	0.000664	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Prednisone—multiple sclerosis	3.53e-05	0.000663	CcSEcCtD
Emtricitabine—Nausea—Prednisolone—multiple sclerosis	3.53e-05	0.000663	CcSEcCtD
Emtricitabine—Pruritus—Dexamethasone—multiple sclerosis	3.51e-05	0.000659	CcSEcCtD
Emtricitabine—Pruritus—Betamethasone—multiple sclerosis	3.51e-05	0.000659	CcSEcCtD
Emtricitabine—Skin disorder—Methotrexate—multiple sclerosis	3.51e-05	0.000658	CcSEcCtD
Emtricitabine—Vomiting—Triamcinolone—multiple sclerosis	3.48e-05	0.000653	CcSEcCtD
Emtricitabine—Vomiting—Methylprednisolone—multiple sclerosis	3.47e-05	0.000651	CcSEcCtD
Emtricitabine—Rash—Triamcinolone—multiple sclerosis	3.45e-05	0.000647	CcSEcCtD
Emtricitabine—Dermatitis—Triamcinolone—multiple sclerosis	3.44e-05	0.000647	CcSEcCtD
Emtricitabine—Rash—Methylprednisolone—multiple sclerosis	3.44e-05	0.000646	CcSEcCtD
Emtricitabine—Dermatitis—Methylprednisolone—multiple sclerosis	3.44e-05	0.000645	CcSEcCtD
Emtricitabine—Urticaria—Prednisone—multiple sclerosis	3.43e-05	0.000644	CcSEcCtD
Emtricitabine—Headache—Triamcinolone—multiple sclerosis	3.43e-05	0.000643	CcSEcCtD
Emtricitabine—Headache—Methylprednisolone—multiple sclerosis	3.42e-05	0.000642	CcSEcCtD
Emtricitabine—Abdominal pain—Prednisone—multiple sclerosis	3.42e-05	0.000641	CcSEcCtD
Emtricitabine—Body temperature increased—Prednisone—multiple sclerosis	3.42e-05	0.000641	CcSEcCtD
Emtricitabine—Diarrhoea—Betamethasone—multiple sclerosis	3.39e-05	0.000637	CcSEcCtD
Emtricitabine—Diarrhoea—Dexamethasone—multiple sclerosis	3.39e-05	0.000637	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	3.29e-05	0.000618	CcSEcCtD
Emtricitabine—Dizziness—Betamethasone—multiple sclerosis	3.28e-05	0.000616	CcSEcCtD
Emtricitabine—Dizziness—Dexamethasone—multiple sclerosis	3.28e-05	0.000616	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—multiple sclerosis	3.27e-05	0.000613	CcSEcCtD
Emtricitabine—Nausea—Triamcinolone—multiple sclerosis	3.25e-05	0.00061	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—multiple sclerosis	3.24e-05	0.000609	CcSEcCtD
Emtricitabine—Nausea—Methylprednisolone—multiple sclerosis	3.24e-05	0.000608	CcSEcCtD
Emtricitabine—Dyspnoea—Methotrexate—multiple sclerosis	3.22e-05	0.000604	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisone—multiple sclerosis	3.18e-05	0.000598	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—multiple sclerosis	3.18e-05	0.000597	CcSEcCtD
Emtricitabine—Vomiting—Dexamethasone—multiple sclerosis	3.15e-05	0.000592	CcSEcCtD
Emtricitabine—Vomiting—Betamethasone—multiple sclerosis	3.15e-05	0.000592	CcSEcCtD
Emtricitabine—Rash—Dexamethasone—multiple sclerosis	3.13e-05	0.000587	CcSEcCtD
Emtricitabine—Rash—Betamethasone—multiple sclerosis	3.13e-05	0.000587	CcSEcCtD
Emtricitabine—Dermatitis—Betamethasone—multiple sclerosis	3.13e-05	0.000587	CcSEcCtD
Emtricitabine—Dermatitis—Dexamethasone—multiple sclerosis	3.13e-05	0.000587	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	3.12e-05	0.000585	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—multiple sclerosis	3.11e-05	0.000584	CcSEcCtD
Emtricitabine—Headache—Dexamethasone—multiple sclerosis	3.11e-05	0.000583	CcSEcCtD
Emtricitabine—Headache—Betamethasone—multiple sclerosis	3.11e-05	0.000583	CcSEcCtD
Emtricitabine—Asthenia—Prednisone—multiple sclerosis	3.1e-05	0.000582	CcSEcCtD
Emtricitabine—Pain—Methotrexate—multiple sclerosis	3.09e-05	0.00058	CcSEcCtD
Emtricitabine—Pruritus—Prednisone—multiple sclerosis	3.06e-05	0.000574	CcSEcCtD
Emtricitabine—Diarrhoea—Prednisone—multiple sclerosis	2.96e-05	0.000555	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.95e-05	0.000554	CcSEcCtD
Emtricitabine—Nausea—Dexamethasone—multiple sclerosis	2.95e-05	0.000553	CcSEcCtD
Emtricitabine—Nausea—Betamethasone—multiple sclerosis	2.95e-05	0.000553	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—multiple sclerosis	2.87e-05	0.000538	CcSEcCtD
Emtricitabine—Dizziness—Prednisone—multiple sclerosis	2.86e-05	0.000536	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—multiple sclerosis	2.85e-05	0.000536	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—multiple sclerosis	2.85e-05	0.000536	CcSEcCtD
Emtricitabine—Vomiting—Prednisone—multiple sclerosis	2.75e-05	0.000516	CcSEcCtD
Emtricitabine—Rash—Prednisone—multiple sclerosis	2.72e-05	0.000511	CcSEcCtD
Emtricitabine—Dermatitis—Prednisone—multiple sclerosis	2.72e-05	0.000511	CcSEcCtD
Emtricitabine—Headache—Prednisone—multiple sclerosis	2.71e-05	0.000508	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—multiple sclerosis	2.66e-05	0.000499	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—multiple sclerosis	2.59e-05	0.000486	CcSEcCtD
Emtricitabine—Nausea—Prednisone—multiple sclerosis	2.57e-05	0.000482	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—multiple sclerosis	2.55e-05	0.00048	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—multiple sclerosis	2.47e-05	0.000464	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—multiple sclerosis	2.39e-05	0.000448	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—multiple sclerosis	2.3e-05	0.000431	CcSEcCtD
Emtricitabine—Rash—Methotrexate—multiple sclerosis	2.28e-05	0.000427	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—multiple sclerosis	2.27e-05	0.000427	CcSEcCtD
Emtricitabine—Headache—Methotrexate—multiple sclerosis	2.26e-05	0.000425	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—multiple sclerosis	2.15e-05	0.000403	CcSEcCtD
